Literature DB >> 2848998

Feline immunodeficiency syndrome--a comparison between feline T-lymphotropic lentivirus and feline leukemia virus.

J K Yamamoto1, N C Pedersen, E W Ho, T Okuda, G H Theilen.   

Abstract

A feline T-lymphotrophic lentvirus (FTLV) has recently been isolated from a domestic cat free of feline leukemia virus (FeLV). This virus is distinct from FeLV (an oncornavirus), although they share a common denominator, namely, the ability to cause immunosuppression and induce lymphadenopathy and anemia. Their differences can be revealed by examining the following: the metal requirement for reverse transcriptase activity, the antigenic comparison by Western blot analysis, the different susceptibilities of a variety of feline cells, and the morphology based on electron microscopy. In the serological survey of 1,612 cats surveyed in the USA, 232 (14.4%) were seropositive for antibodies to FTLV, which was lower than for the 42 Canadian cats surveyed of which 8 (19%) were seropositive. Of the 61 cats positive for FeLV, 15 (25%) were also positive for FTLV, giving the impression that coinfection between these two retroviruses plays an important role in the cliniocpathological signs of what was previously thought to be solely an FeLV syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848998

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  Interleukin-2 and concanavalin A upregulate a cat2 isoform encoding a high affinity L-arginine transporter in feline lymphocytes.

Authors:  B R Stevens; M Tellier; W Harvey; D H Feldman; J Bosworth
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

2.  Isolation of a highly cytopathic lentivirus from a nondomestic cat.

Authors:  M C Barr; L Zou; D L Holzschu; L Phillips; F W Scott; J W Casey; R J Avery
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 3.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

4.  A survey of FIV antibodies and FeLV antigens in free-roaming cats in the capital area of Finland.

Authors:  A Sukura; T Salminen; L A Lindberg
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

5.  In vivo antiretroviral activity of stampidine in chronically feline immunodeficiency virus-infected cats.

Authors:  Fatih M Uckun; Chun-Lin Chen; Peter Samuel; Sharon Pendergrass; T K Venkatachalam; Barbara Waurzyniak; Sanjive Qazi
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

6.  Antiretroviral spermicide WHI-07 prevents vaginal and rectal transmission of feline immunodeficiency virus in domestic cats.

Authors:  Osmond J D'Cruz; Barbara Waurzyniak; Fatih M Uckun
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

Review 7.  Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine.

Authors:  Bikash Sahay; Janet K Yamamoto
Journal:  Viruses       Date:  2018-05-22       Impact factor: 5.048

8.  FIV-infected cats respond to short-term rHuG-CSF treatment which results in anti-G-CSF neutralizing antibody production that inactivates drug activity.

Authors:  K Phillips; M Arai; T Tanabe; R Raskin; M Volz; E W Uhl; J K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2005-08-10       Impact factor: 2.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.